Publications:88
Ernest Turro, PhD
About Me
Language
English
Position
ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Multi-Disciplinary Training Areas
Genetics and Genomic Sciences [GGS]
Publications
Selected Publications
- Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk. Yanki Yarman, Xuefei Zhao, Hyunsook Ahn, Hannah Thomson, Amrita Sarkar, Tian Yuan, Meghan Roberts, Jeremy G.T. Wurtzel, Scott L. Diamond, John J.G. Tesmer, Deborah L. French, Maurizio Tomaiuolo, Ernest Turro, William J. Astle, Lawrence E. Goldfinger, Steven E. McKenzie, Jeffrey L. Benovic, Timothy J. Stalker, Mortimer Poncz, Peisong Ma. Blood
- Human missense variants in F3 impair the initiation of blood coagulation. Shabbir A. Ansari, Marisa A. Brake, Nishtha Pathak, James T. Flaumenhaft, Jacob G. Ludington, Natasha Panwar, Ernest Turro, Sol Schulman. Blood
- Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder. Daniel Greene, Rodrigo Mendez, Jon Lees, Mafalda Barbosa, Alessandro Bruselles, Luigi Chiriatti, Federico Ferraro, Cecilia Mancini, Rachel Schot, Frank Sleutels, Enrico Bertini, Devon E. Bonner, Arjan Bouman, Alice S. Brooks, Thomas A. Cassini, Kimberly M. Ezell, Natalia Gomez-Ospina, Tjitske Kleefstra, Michael O’Donoghue, Lynette Rives, Vandana Shashi, Rebecca C. Spillmann, Mohamed Wafik, Kathleen Freson, Tahsin Stefan Barakat, Marco Tartaglia, Jonathan A. Bernstein, Andrew D. Mumford, Matthew T. Wheeler, Ernest Turro. Nature Genetics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Turro during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- Tachyon Ventures LLC
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.